Mark Clements, MD, PhD, CPI, FAAP is chief medical officer at Glooko Inc., professor of pediatrics at the University of Missouri-Kansas City School of Medicine, and a pediatric endocrinologist at Children’s Mercy Kansas City, where he serves as director of pediatric endocrine/diabetes clinical research. He is also a clinical researcher of new diabetes treatments and technologies, having served as a principal investigator or co-investigator in more than 30 clinical studies and patient registries.